Literature DB >> 31980545

Prenatal Repair of Myelomeningocele and School-age Functional Outcomes.

Amy J Houtrow1, Elizabeth A Thom2, Jack M Fletcher3, Pamela K Burrows4, N Scott Adzick5, Nina H Thomas5, John W Brock6, Timothy Cooper6, Hanmin Lee7, Larissa Bilaniuk5, Orit A Glenn7, Sumit Pruthi6, Cora MacPherson4, Diana L Farmer8, Mark P Johnson5, Lori J Howell5, Nalin Gupta7, William O Walker9.   

Abstract

BACKGROUND AND OBJECTIVES: The Management of Myelomeningocele Study (MOMS), a randomized trial of prenatal versus postnatal repair for myelomeningocele, found that prenatal surgery resulted in reduced hindbrain herniation and need for shunt diversion at 12 months of age and better motor function at 30 months. In this study, we compared adaptive behavior and other outcomes at school age (5.9-10.3 years) between prenatal versus postnatal surgery groups.
METHODS: Follow-up cohort study of 161 children enrolled in MOMS. Assessments included neuropsychological and physical evaluations. Children were evaluated at a MOMS center or at a home visit by trained blinded examiners.
RESULTS: The Vineland composite score was not different between surgery groups (89.0 ± 9.6 in the prenatal group versus 87.5 ± 12.0 in the postnatal group; P = .35). Children in the prenatal group walked without orthotics or assistive devices more often (29% vs 11%; P = .06), had higher mean percentage scores on the Functional Rehabilitation Evaluation of Sensori-Neurologic Outcomes (92 ± 9 vs 85 ± 18; P < .001), lower rates of hindbrain herniation (60% vs 87%; P < .001), had fewer shunts placed for hydrocephalus (49% vs 85%; P < .001) and, among those with shunts, fewer shunt revisions (47% vs 70%; P = .02) than those in the postnatal group. Parents of children repaired prenatally reported higher mean quality of life z scores (0.15 ± 0.67 vs 0.11 ± 0.73; P = .008) and lower mean family impact scores (32.5 ± 7.8 vs 37.0 ± 8.9; P = .002).
CONCLUSIONS: There was no significant difference between surgery groups in overall adaptive behavior. Long-term benefits of prenatal surgery included improved mobility and independent functioning and fewer surgeries for shunt placement and revision, with no strong evidence of improved cognitive functioning.
Copyright © 2020 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2020        PMID: 31980545      PMCID: PMC6993457          DOI: 10.1542/peds.2019-1544

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  24 in total

Review 1.  Worst-rank score analysis with informatively missing observations in clinical trials.

Authors:  J M Lachin
Journal:  Control Clin Trials       Date:  1999-10

2.  The Chiari II malformation: cause and impact.

Authors:  David G McLone; Mark S Dias
Journal:  Childs Nerv Syst       Date:  2003-08-12       Impact factor: 1.475

3.  Endoscopic coverage of fetal open myelomeningocele in utero.

Authors:  J P Bruner; N E Tulipan; W O Richards
Journal:  Am J Obstet Gynecol       Date:  1997-01       Impact factor: 8.661

4.  Factors Associated with Mobility Outcomes in a National Spina Bifida Patient Registry.

Authors:  Brad E Dicianno; Amol Karmarkar; Amy Houtrow; Theresa M Crytzer; Katelyn M Cushanick; Andrew McCoy; Pamela Wilson; James Chinarian; Jacob Neufeld; Kathryn Smith; Diane M Collins
Journal:  Am J Phys Med Rehabil       Date:  2015-12       Impact factor: 2.159

5.  Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus.

Authors:  J P Bruner; N Tulipan; R L Paschall; F H Boehm; W F Walsh; S R Silva; M Hernanz-Schulman; L H Lowe; G W Reed
Journal:  JAMA       Date:  1999-11-17       Impact factor: 56.272

6.  In utero surgery rescues neurological function at birth in sheep with spina bifida.

Authors:  M Meuli; C Meuli-Simmen; G M Hutchins; C D Yingling; K M Hoffman; M R Harrison; N S Adzick
Journal:  Nat Med       Date:  1995-04       Impact factor: 53.440

7.  A randomized trial of prenatal versus postnatal repair of myelomeningocele.

Authors:  N Scott Adzick; Elizabeth A Thom; Catherine Y Spong; John W Brock; Pamela K Burrows; Mark P Johnson; Lori J Howell; Jody A Farrell; Mary E Dabrowiak; Leslie N Sutton; Nalin Gupta; Noel B Tulipan; Mary E D'Alton; Diana L Farmer
Journal:  N Engl J Med       Date:  2011-02-09       Impact factor: 91.245

8.  The paralysis associated with myelomeningocele: clinical and experimental data implicating a preventable spinal cord injury.

Authors:  D S Heffez; J Aryanpur; G M Hutchins; J M Freeman
Journal:  Neurosurgery       Date:  1990-06       Impact factor: 4.654

9.  Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement.

Authors:  Noel Tulipan; John C Wellons; Elizabeth A Thom; Nalin Gupta; Leslie N Sutton; Pamela K Burrows; Diana Farmer; William Walsh; Mark P Johnson; Larry Rand; Susan Tolivaisa; Mary E D'alton; N Scott Adzick
Journal:  J Neurosurg Pediatr       Date:  2015-09-15       Impact factor: 2.375

10.  The Management of Myelomeningocele Study: full cohort 30-month pediatric outcomes.

Authors:  Diana L Farmer; Elizabeth A Thom; John W Brock; Pamela K Burrows; Mark P Johnson; Lori J Howell; Jody A Farrell; Nalin Gupta; N Scott Adzick
Journal:  Am J Obstet Gynecol       Date:  2017-12-12       Impact factor: 8.661

View more
  13 in total

1.  The Construction of a Predictive Composite Index for Decision-Making of CSF Diversion Surgery in Pediatric Patients following Prenatal Myelomeningocele Repair.

Authors:  F T Mangano; M Altaye; C B Stevenson; W Yuan
Journal:  AJNR Am J Neuroradiol       Date:  2022-07-28       Impact factor: 4.966

2.  Impact of Gestational Age on Neuroprotective Function of Placenta-Derived Mesenchymal Stromal Cells.

Authors:  Sarah C Stokes; Sandra K Kabagambe; Chelsey J Lee; Aijun Wang; Diana L Farmer; Priyadarsini Kumar
Journal:  J Surg Res       Date:  2022-01-29       Impact factor: 2.417

3.  Preliminary Evaluation of a Novel Fetal Guinea Pig Myelomeningocele Model.

Authors:  Sarah C Stokes; Kaeli J Yamashiro; Melissa A Vanover; Laura A Galganski; Jordan E Jackson; Christina M Theodorou; Christopher D Pivetti; Diana Lee Farmer; Aijun Wang
Journal:  Biomed Res Int       Date:  2021-08-13       Impact factor: 3.411

4.  A New Ethical Framework for Assessing the Unique Challenges of Fetal Therapy Trials.

Authors:  Saskia Hendriks; Christine Grady; David Wasserman; David Wendler; Diana W Bianchi; Benjamin E Berkman
Journal:  Am J Bioeth       Date:  2021-01-16       Impact factor: 11.229

Review 5.  Fetal myelomeningocele repair: a narrative review of the history, current controversies and future directions.

Authors:  Kaeli J Yamashiro; Diana L Farmer
Journal:  Transl Pediatr       Date:  2021-05

Review 6.  Spinal Cord Injury in Myelomeningocele: Prospects for Therapy.

Authors:  Karolina Janik; Meredith A Manire; George M Smith; Barbara Krynska
Journal:  Front Cell Neurosci       Date:  2020-06-30       Impact factor: 5.505

7.  Closure of a large lumbosacral myelomeningocele defect with a human pericardial graft: a case report.

Authors:  Yamila Basilotta Marquez; Agustin Ruiz Johnson; Andrea Uez Pata; Beatriz Mantese
Journal:  Childs Nerv Syst       Date:  2021-06-18       Impact factor: 1.475

8.  Neurosurgical procedures for children with myelomeningocele after fetal or postnatal surgery: a comparative effectiveness study.

Authors:  Gordon Worley; Rachel G Greenberg; Brandon G Rocque; Tiebin Liu; Brad E Dicianno; Jonathan P Castillo; Elisabeth A Ward; Tonya R Williams; Jeffrey P Blount; John S Wiener
Journal:  Dev Med Child Neurol       Date:  2021-01-02       Impact factor: 5.449

9.  Efficacy of clinical-grade human placental mesenchymal stromal cells in fetal ovine myelomeningocele repair.

Authors:  Christina M Theodorou; Sarah C Stokes; Jordan E Jackson; Christopher D Pivetti; Priyadarsini Kumar; Kaeli J Yamashiro; Zachary J Paxton; Lizette Reynaga; Alicia A Hyllen; Aijun Wang; Diana L Farmer
Journal:  J Pediatr Surg       Date:  2021-06-05       Impact factor: 2.549

10.  Fetoscopic myelomeningocoele closure: Is the scientific evidence enough to challenge the gold standard for prenatal surgery?

Authors:  E Joanne Verweij; Martine C de Vries; Esther J Oldekamp; Alex J Eggink; Dick Oepkes; Femke Slaghekke; Jochem K H Spoor; Jan A Deprest; Jena L Miller; Ahmet A Baschat; Philip L J DeKoninck
Journal:  Prenat Diagn       Date:  2021-04-05       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.